Animal Models

In the Feb. 18, 1991, issue of The Scientist [page 12], there is a letter entitled "Animal Rights" by Melissa B. Goldman, raising questions about Albert M. Kligman's commentary on this subject [The Scientist, Oct. 29, 1990, page 16]. The examples she gives deserve a critical analysis. For those diseases that occur essentially only in humans, like cardiovascular disease, only epidemiology could be used to show a relationship like that between cholesterol blood levels and coronary heart disease

Written byLeon Freeman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the Feb. 18, 1991, issue of The Scientist [page 12], there is a letter entitled "Animal Rights" by Melissa B. Goldman, raising questions about Albert M. Kligman's commentary on this subject [The Scientist, Oct. 29, 1990, page 16]. The examples she gives deserve a critical analysis.

For those diseases that occur essentially only in humans, like cardiovascular disease, only epidemiology could be used to show a relationship like that between cholesterol blood levels and coronary heart disease.

However, once the need to lower lipids became clear, it was essential to use animals to discover drugs that would lower cholesterol and other lipids. Animals were essential both for discovery of drugs and for screening out drugs that were unsafe.

Vaccines could not have been developed without animal models. Otherwise, proof of efficacy and safety must be established in people. We are faced with this prospect in AIDS, since the animal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies